AngioDynamics, Inc.
ANGO
$9.50
-$0.105-1.09%
NASDAQ
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.15% | 7.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.15% | 7.93% | |||
| Cost of Revenue | 0.63% | 7.06% | |||
| Gross Profit | -2.63% | 8.66% | |||
| SG&A Expenses | 0.04% | -1.69% | |||
| Depreciation & Amortization | 1.41% | -0.31% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.95% | 2.25% | |||
| Operating Income | -31.12% | 41.80% | |||
| Income Before Tax | 59.36% | 14.35% | |||
| Income Tax Expenses | 98.18% | -182.71% | |||
| Earnings from Continuing Operations | 58.96% | 16.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 58.96% | 16.10% | |||
| EBIT | -31.12% | 41.80% | |||
| EBITDA | -118.35% | 193.09% | |||
| EPS Basic | 58.88% | 16.65% | |||
| Normalized Basic EPS | 77.48% | 42.11% | |||
| EPS Diluted | 58.08% | 16.65% | |||
| Normalized Diluted EPS | 77.48% | 42.11% | |||
| Average Basic Shares Outstanding | -0.17% | 0.66% | |||
| Average Diluted Shares Outstanding | -0.17% | 0.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||